GlassScriptPhysician profile
Stephanie A Posey
NPI 1760920342
$2,371.03
in general payments reported to CMS, 2019-2025
13 companies · $28.87 in 2025
The $28.87 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,482 · 2022: $430 · 2023: $195 · 2024: $236 · 2025: $28.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,590.23 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $236.92 | 2022-2024 | Rezum Generator, Lithovue |
| Teleflex LLC | $162.84 | 2021-2022 | |
| Astellas Pharma US INC | $113.31 | 2022-2023 | Myrbetriq |
| Urogen Pharma, INC. | $53.39 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $49.07 | 2022-2023 | Opdivo |
| Bayer Healthcare Pharmaceuticals INC. | $43.14 | 2022-2024 | |
| Olympus America INC. | $39.14 | 2023-2024 | Visera Elite II Video System Center Olympus Otv-S300, Hd Camera Head, Itind System |
| Calyxo, INC. | $26.91 | 2024 | Cvac Aspiration System |
| Abbvie INC. | $15.18 | 2022 | |
| Lilly USA, LLC | $15.05 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $13.82 | 2025 | Enflonsia |
| Antares Pharma, INC. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Posey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.